Searchable abstracts of presentations at key conferences in endocrinology

ea0081p640 | Endocrine-Related Cancer | ECE2022

Short fasting test as reliable and effective tool to diagnose insulinoma

Mikovic Nevena , Zamponi Virginia , Mazzilli Rossella , Russo Flaminia , fazzalari beatrice , Faggiano Antongiulio

Introduction: Insulinomas are rare pancreatic NETs presenting with chronic hypoglycaemia. Current guidelines for diagnosis require a prolonged fasting test (72 h), which implies hospitalization and is difficult to perform, delaying prompt diagnosis and treatment. It has been reported that 65 to 85% of insulinomas could be diagnosed after less of a 24h fasting period and 94 to 95.7% within 48h, although a shorter test for diagnosis has not yet been standardized.<p class="ab...

ea0073aep575 | Reproductive and Developmental Endocrinology | ECE2021

Erectile dysfunction as a marker of newly diagnosed endocrine and metabolic disorders

Mazzilli Rossella , Zamponi Virginia , Olana Soraya , bollanti lucilla , Mikovic Nevena , Napoli Angela , Conti Francesco , Pugliese Giuseppe , Faggiano Antongiulio

AimThe aim of this study was to evaluate: a) the prevalence of a previously unknown endocrine / metabolic dysfunction, namely hypogonadism, thyroid dysfunction, hyperprolactinemia, and diabetes or prediabetes, in a population of patients affected by Erectile Dysfunction (ED); b) the differences in ED severity according to the presence/absence of specific endocrine / metabolic dysfunctions.Material and Methods...

ea0081p388 | Endocrine-Related Cancer | ECE2022

Endocrine-metabolic disorders in patients with gastroenteropancreatic and lung neuroendocrine tumors

Zamponi Virginia , Mazzilli Rossella , Russo Flaminia , Mikovic Nevena , Rinzivillo Maria , Magi Ludovica , Trabalza Marinucci Beatrice , Siciliani Alessandra , Panzuto Francesco , Faggiano Antongiulio

Background: Neuroendocrine tumors (NETs) are characterized by long survival and slow progression. In the clinical practice adifferent types of endocrine-metabolic disorders can occur. Such disorders are either comorbidities related to the neoplasm or side effects of specific oncological treatments. The aim of this study is to evaluate type and prevalence of the endocrine-metabolic disorders in patients with gastroenteropancreatic (GEP) and lung NETs.Mate...